Table 1 The cumulative incidence of Terson syndrome in patients with treated subarachnoid hemorrhage in the Korean population from 2011 to 2015 according to age groups and sex.

From: Incidence of Terson Syndrome in Treated Subarachnoid Hemorrhage in South Korea: a National Health Insurance Database Study

 

tSAH

(Person-years)

Terson syndrome (n)

Cumulative

incidence

(%)

95% CI

OR (95% CI)*

p-value

Age

(years)

18–24

95

0

0

 

13.98 (2.31–84.589)a

0.913

25–29

194

3

1.55

(0–3.28)

12.11 (2.495–58.744)a

0.917

30–34

523

7

1.34

(0.35–2.32)

13.99 (3.208–60.99)a

0.913

35–39

1,101

17

1.54

(0.82–2.27)

13.94 (3.33–58.315)a

0.913

40–44

2,229

34

1.53

(1.02–2.03)

11.56 (2.784–47.976)a

0.918

45–49

3,255

41

1.26

(0.88–1.64)

9.04 (2.169–37.678)a

0.924

50–54

3,658

36

0.98

(0.66–1.30)

8.50 (2.026–35.676)a

0.925

55–59

3,258

30

0.92

(0.59–1.25)

6.59 (1.521–28.594)a

0.931

60–64

2,403

17

0.71

(0.37–1.04)

2.83 (0.57–14.041)a

0.951

65–69

1,986

6

0.30

(0.06–0.54)

1

Reference

70–74

1,886

2

0.11

(0–0.25)

2.141 (0.357–12.829)a

0.958

75–79

1,328

3

0.23

(0–0.48)

NE

 

80–84

661

0

0

 

NE

 

85–89

235

0

0

 

NE

 

90+

52

0

0

   

Sex

Male

8,424 (36.8%)

93 (47.4%)

1.10

(0.88–1.33)

1.548 (1.168–2.051)b

0.004

Female

14,440 (63.2%)

103 (52.6%)

0.71

(0.58–0.85)

1

Reference

Total

 

22,864

196

0.86

(0.74–0.98)

13.979 (2.31–84.589)

0.9132

  1. CI = confidence interval; NA = not applicable; NE = no estimate; OR = odds ratio; tSAH = treated subarachnoid hemorrhage.
  2. *OR was estimated using sex-adjusted logistic regression analysis.
  3. aOR adjusted for sex and year; bOR adjusted for age and year; Chi-square test.